Search by Drug Name or NDC

    NDC 00527-3291-43 Levothyroxine Sodium 300 ug/1 Details

    Levothyroxine Sodium 300 ug/1

    Levothyroxine Sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc. The primary component is LEVOTHYROXINE SODIUM.

    Product Information

    NDC 00527-3291
    Product ID 0527-3291_0dfc6488-2bcb-6e01-e063-6394a90a8b2c
    Associated GPIs 28100010100345
    GCN Sequence Number 006657
    GCN Sequence Number Description levothyroxine sodium TABLET 300 MCG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 26329
    HICL Sequence Number 002849
    HICL Sequence Number Description LEVOTHYROXINE SODIUM
    Brand/Generic Generic
    Proprietary Name Levothyroxine Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levothyroxine Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units ug/1
    Substance Name LEVOTHYROXINE SODIUM
    Labeler Name Lannett Company, Inc
    Pharmaceutical Class Thyroxine [CS], l-Thyroxine [EPC]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021342
    Listing Certified Through 2025-12-31

    Package

    NDC 00527-3291-43 (00527329143)

    NDC Package Code 0527-3291-43
    Billing NDC 00527329143
    Package 1000 TABLET in 1 BOTTLE (0527-3291-43)
    Marketing Start Date 2020-08-03
    NDC Exclude Flag N
    Pricing Information N/A